Cannabis Seeds

CBD

Colorado: 'First Ever' Extended Release Cannabis Capsule Released

WanaCapsExtendedReleaseCapsules

Wana Products on Tuesday announced the launch of WanaCaps XR, a family of extended release cannabis capsules that provide medicinal benefits for up to 12 hours.

Wana Products partnered with Cannabics Pharmaceuticals Inc., a United States-based Drug Development Company with research and development in Israel, that developed the proprietary technology behind the extended release formulation.

WanaCaps XR will be offered in three different formulations: capsules with a 10:1 CBD to THC ratio (WanaCaps XR High CBD Capsules), a 10:1 THC to CBD ratio (WanaCaps XR High THC Capsules), and a balanced formulation with 1:1 THC:CBD ratio (WanaCaps XR THC/CBD Balanced Capsules).

“WanaCaps XR represents the next generation in the evolution of marijuana for the medical community,” said Nancy Whiteman, co-owner of Wana Products. “The extended release formulation enables patients to dose once or twice daily so they can get on with their lives without the constant need to be thinking about re-dosing. Additionally, WanaCaps XR are formulated to be highly bio-available so patients feel the therapeutic impact quickly.”

“The new capsules also address one of the major concerns of cannabis patients, which is that the initial high peak of cannabinoid activity soon after administration which can cause uncomfortable side effects such as disorientation and dizziness,” Whiteman said. “Instead, with WanaCaps XR, patients experience a long-lasting, stable effect for up to 10 hours without the ups and downs. Overall, it’s just a much better experience for patients.”

Israel: Researchers Eliminate 60% of Myeloma Cells With Cannabis-Based Treatments

OneWorldCannabis(logo)

As the possibilities for cannabis-based treatments continue to make headlines in the medical world, One World Cannabis, a medical-cannabis research company, has announced that the initial results of its landmark study on treating multiple myeloma with cannabis-based solutions were extremely promising. After a series of tests using cannabis-based treatments, researchers were able to eradicate 60 percent of multiple myeloma cells.

The disease is one of the most deadly hematologic cancers and individuals diagnosed with the disease often have about a 50 percent survival rate.

OWC Pharmaceutical Research Corp. on Wednesday announced that its wholly owned subsidiary, One World Cannabis Ltd., an Israel-based developer of cannabinoid-based therapies targeting a variety of different indications, has received the first basic science study (lab) results on the effect of several combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma cell line RPMI8226.

Based on the results, One World Cannabis will submit the clinical trial protocol to the IRB (Helsinki committee). The company expects to receive institutional review board approval for the study within 6-9 weeks.

The OWC multiple myeloma study was done by three repetitive tests on the effect of cannabis extract with various combination ratios of THC/CBD and pure THC and CBD (50 percent concentration). The results present more than 60 percent malignant cell death. More results of pure THC and CBD are under further analysis.

Puerto Rico: Cannabis Treatment Helps 9-Year-Old Boy Speak His First Words

KalelSantiagoWithParentsAbielAndGladys[YahooParenting]

By Steve Elliott
Hemp News

Kalel Santiago of Puerto Rico is just 9 years old, but he hasn't had an easy nine years. At just 10 months old, he was diagnosed with the rare childhood cancer neuroblastoma, and he spent more than two years going through surgery, chemotherapy, and radiation treatments. Then he was diagnosed with severe, non-verbal autism.

"While he was in the hospital, we noticed he didn't speak at all and had some behavior that wasn't right, like hand flapping, and walking on his toes," said Abiel Gomez Santiago, Kalel's father, from their home in Aguada, reports Beth Greenfield at Yahoo Parenting. "But we waited until he was 3 and cancer-free to look at his behavior."

Abiel and his wife Gladys did a crash course in autism. They tried various therapies, and eventually happened upon a treatment that would change their lives: hemp oil, rich in cannabidiol (CBD), which has anecdotally been shown to dramatically ease symptoms of both epilepsy and autism.

They began giving their son twice daily doses of a CBD oral spray, and the results were startling -- Kalel started talking in just two days after a lifetime of silence.

“He surprised us in school by saying the vowels, A-E-I-O-U. It was the first time ever,” Abiel said. “You can’t imagine the emotion we had, hearing Kalel’s voice for the first time. It was amazing.

Florida: Judge Clears Way For Non-Euphoric Medical Marijuana

FloridaFlagMedicalMarijuana(USE)

By Steve Elliott
Hemp News

Florida regulators said they expect to provide access to a strain of non-euphoric marijuana for medical purposes by the end of this year after a Tallahassee judge last week dismissed the final challenge to the long-awaited rule.

The Florida Department of Health is expected to start accepting applications within three weeks from eligible growers within three weeks for the strain of cannabis that is low in THC, the main "high"-inducing component, and high in cannabidiol (CBD), which, like THC, also has medicinal effects, reports Mary Ellen Klas at the Miami Herald.

Growers could start selling to eligible patients who are put on a state-run "compassionate use registry" within months.

"I am one happy legislator," said Rep. Matt Gaetz (R-Shalimar), one of the sponsors of the 2014 bill designed to allow the development and cultivation of the "Charlotte's Web" strain of low-THC cannabis to help patients suffering from epileptic seizures and other ailments. (The clueless legislators passed the law naming a specific strain of low-CBD marijuana, evidently unaware that there are lots of low-CBD medicinal strains, but in the process making the Stanley Brothers -- who control the supply of Charlotte's Web -- very happy.)

South Carolina: Mom Legally Making, Selling Medical Marijuana CBD Extract

PalmettoSynergisticResearch

By Steve Elliott
Hemp News

A mother in South Carolina is manufacturing cannabis oil, legally. The oil is high in cannabidiol (CBD), a non-psychoactive but medicinal component of marijuana that is now legal in the state under S. 839, which allows for consumable hemp products with less than .3 percent of THC.

"I'm building my company here," said Janel Ralph, reports Molly Grantham at WISTV.com. "I think it'll be up and running in maybe six months. But I'm an optimist. I guess I can't say exactly on the timeline."

Janel's company, Palmetto Synergistic Research, will specialize in CBD oil.

Because of the controversy surrounding marijuana, Ralph is keeping her location secret.

"There will be people who would intentionally try to steal it not knowing that it's hemp," she said. "Criminals could hear I'm manufacturing medical marijuana and think they could take it.

"They wouldn't understand that what I'm making has such a low THC, that even if they took they plants they couldn't smoke it or sell it as marijuana," she said. "You can't get high on what I'm making."

Ralph started it all last year because of her five-year-old daughter, Harmony, who has a genetic condition called lissencephaly. Harmony's brain is missing one of her chromosomes, and she has lots of seizures. Multiple pharmaceuticals didn't work.

Texas: House Approves Flawed Medical Marijuana Bill; Will Go To Governor For Signature

TexasMedicalMarijuanaPolicyReform[ProgressTexas]

Bill is intended to allow access to low-THC marijuana extracts for qualifying seizure patients; House fails to pass amendment to fix major problem

The Texas State House on Monday approved a bill 96-34 intended to allow qualifying patients with intractable seizure conditions to access a marijuana extract containing high levels of cannabidiol, or CBD, and only trace levels of THC. SB 339, sponsored by Sen. Kevin Eltife (R-Tyler), is extremely unlikely to provide patients with relief because it requires doctors to engage in conduct that is prohibited by federal law.

SB 339 previously passed the Senate on May 7. It now heads to Gov. Greg Abbott.

“On a certain level, the legislature should be commended for acknowledging the medical value of marijuana, and it is an historic vote in that sense,” said Heather Fazio, Texas political director for the Marijuana Policy Project (MPP). “Lawmakers missed several opportunities to amend the bill in ways that could have provided real relief to countless Texans. Not a single patient will be helped by this legislation.”

SB 339 requires doctors to “prescribe” marijuana to patients, which exposes doctors to federal criminal sanctions. By contrast, doctors “recommend” medical marijuana or “certify” patients to use medical marijuana in the 23 states with comprehensive medical marijuana laws and the District of Columbia. Unlike “prescriptions,” recommendations and certifications are federally legal and protected under the First Amendment.

Illinois: Desktop Cannabis Potency Measurement System To Be Unveiled At Marijuana Business Expo

LuminarySageAnalytics

Sage Analytics, developers of portable laboratory quality cannabis potency measurement systems, on Wednesday announced that they will introduce their newest product, the Luminary™ Beacon, at the Marijuana Business Conference and Expo, to be held in Chicago, May 19-21.

Unlike any other product on the market, according to Sage, "the Beacon provides instant, on-the-spot feedback, and is expected to be a vital tool toward standardization in cannabis potency profiling, and accuracy in consumer information and labeling."

"The Luminary™ Beacon is a small, portable desktop system that is simple to use in any location and requires little training to obtain on-site, instantaneous, laboratory-grade accurate measurement of THC, CBD, and CBN," the company's press release states. "Unlike gas chromatography (GC) or high performance liquid chromatography (HPLC), the Luminary™ Beacon uses optical spectroscopy (light) to instantly measure the potency of cannabis products at the molecular level.

Spectroscopy offers a number of distinct advantages over alternative methods, according to Sage Analytics: It is portable and can be used virtually anywhere, it is easy to use and requires just minimal training to become proficient, requires no toxic chemicals for preparation or analysis, and it leaves the sample intact for future use.

Texas: Senate Approves Unworkable Medical Marijuana Bill

TexasMedicalMarijuanaPolicyReform[ProgressTexas]

House will now consider measure that is intended to allow access to low-THC marijuana extract for qualifying seizure patients

The Texas State Senate on Thursday approved a bill 26-5 that is intended to allow qualifying patients with intractable seizure conditions to access a marijuana extract containing high levels of cannabidiol, or CBD, and only trace levels of THC. SB 339, introduced by Sen. Kevin Eltife (R-Tyler), will now be considered by the state House of Representatives.

“We’re pleased to see a majority of the Senate recognizes the medical benefits of marijuana, but it’s of little comfort if patients aren’t able to experience them,” said Heather Fazio, Texas political director for the Marijuana Policy Project (MPP). “Texas needs a comprehensive medical marijuana program that allows patients to take full advantage of the various compounds found in different types of marijuana.”

SB 336 requires doctors to “prescribe” marijuana to patients, which exposes doctors to federal criminal sanctions. By contrast, doctors “recommend” medical marijuana or “certify” patients to use medical marijuana in the 23 states with comprehensive medical marijuana laws and the District of Columbia.

Unlike “prescriptions,” recommendations and certifications are federally legal and protected under the First Amendment.

California: Twyns CBD and THC Mixing Kit Introduced

HempHealthTwyns2-PackCBD-THC

Created for creating a personalized, therapeutic blend of liquid Cannabidiol and THC, the makes of Twyns say it helps people make the best use of cannabis for personal health and wellness

Hemp Health Inc., maker of hemp cannabidiol (CBD) products, on Tuesday released Pharma-CBD Twyns, which the company describes in a press release as "the first legal CBD and THC mixing kit."

Designed for sale at medical marijuana dispensaries, Twyns allows cannabis users to create a therapeutic blend of CBD and THC – without smoking anything.

Twyns will help patients and everyday users personalize cannabis supplementation to meet their health and wellness goals, according to the company.

THC (Tetrahydrocannabinol) is a principal compound in medical marijuana, and while patients normally get THC by smoking the plant, this presents three problems.

First, many patients would prefer not to smoke. Second, most medical marijuana is rich in THC but very low in CBD. Third, individuals react differently to various levels of CBD and THC, but normally they can't choose the proportion of each compound.

According the Hemp Health, Twyns addresses all three problems by allowing users to ingest THC and custom blend both compounds in one liquid solution.

"Twyns" refers to the two bottles contained in the mixing kit. One bottle comes filled with Hemp Health Inc.'s pharma-grade CBD. The second bottle is for liquid THC, and law requires that it be filled by a local dispensary.

Canada: CannTrust Launches New Line of Patient Ready Medical Marijuana Strains

CannTrust-QualityCannabisYouCanTrust.PharmacistControlledAndOperated

CannTrust develops new line of products in a ready to use format at $3.50/gram

CannTrust, "Canada's only pharmacist-controlled and operated producer of medical cannabis," has launched of its own product line of "patient ready strains" at just $3.50 a gram, delivered. "Patient ready," in this context, means that the weed arrives in a pre-ground state, ready for your vaporizer, pipe, bong or paper.

"We are pleased to offer this new format of products carefully selected from our most popular strains of premium cannabis," reads a prepared statement from the company. "The cannabis is from the same harvest and lots as the original bud form of these same strains and is then refined into an already prepared version of medical cannabis that is easy to use by patients, especially in a vaporizer."

"We are very excited about the launch of these products for several reasons that we feel will be beneficial to both patients and their doctors," the company announced.

Each of the three strains are only $3.50/gram, "making this an affordable and easy to use option for medical cannabis," the company announced.

Supreme Formula - Patient Ready
THC: 8.5% • CBD: 0.2%
Indica/Sativa Hybrid
Supreme Formula 8.5 percent THC is a unique blend of the best THC strains. This was specially formulated to meet the recommendations of the College of Family Physicians of Canada's recommendation of up to 9 percent THC, according to CannTrust.

Original Cheese - Patient Ready
THC: 11.4% • CBD: 0.1%
Indica 50% • Sativa 50%

Ohio: New Video Tells Story of Young Epilepsy Patient Without Safe Access To Medical Marijuana

SophiasStory

Moving Video Features Struggle and Frustration of Ohio Family That Has Run Out of Treatment Options for Their Daughter

The Drug Policy Alliance and Learn Liberty have teamed up to tell the emotional story of Sophia Nazzarine, a 7-year-old girl suffering from uncontrolled epilepsy, in a new video.

Between clips of Sophia singing and playing with her parents in her hometown of Cincinnati, the audience is shown saddening footage of Sophia seizing as a newborn, while her parents describe their discovery of Sophia’s epilepsy and their exhaustive struggle to find an effective treatment.

“We’ve tried everything else that they could possibly come up with to try and stop these seizures,” says Scott Nazzarine, Sophia’s father. “None of it has worked. We need legislation that allows our child to get the medicine she needs. But with or without it, we will continue to give our child what she needs to reduce her dangerous seizures.”

Sophia’s story is complemented by interviews with doctors, explaining her condition and the strong potential for its treatment with marijuana.

“The belief is that it’s the cannabidiol portion of [the marijuana plant] that seems to have less intoxicating effects and more of the anti-seizure effects,” explained Dr. Michael D. Privitera, professor of Neurology at the University of Cincinnati.

Georgia: Medical Marijuana Bill Signed By Governor

GeorgiaGovernorNathanDeal

By Steve Elliott
Hemp News

Georgia Gov. Nathan Deal signed a medical marijuana bill into law on Friday in a ceremony on the Capitol steps.

The bill cleared its final legislative hurdle on Thursday when the Georgia House voted 160-1 to approve a Senate compromise that only slightly tweaked the original House version by state Rep. Allen Peake (R-Macon), reports Bill Hendrick at the Associated Press.

After an emotional debate which had lasted, all told, for two years, House Speaker David Ralston hugged Janea Cox, 33, mother of 5-year-old Haleigh Cox, who has intractable epilepsy and is one of the half-a-million Georgians Peake said should benefit from the new law.

"Some days make it all worthwhile," Ralston said.

Peake's bill had already passed the House by a huge margin. It originally called for people with nine medical conditions to be eligible for treatment with cannabis oil that has only minimal amounts of tetrahydrocannabinol (THC), which producers marijuana's characterisic "high."

Colorado: Marijuana Often Laced With Pesticides, Heavy Metals and Fungus

AndyLaFrate

By Steve Elliott
Hemp News

Lab tests from Colorado indicate that while the legal cannabis on store shelves is more potent than the marijuana of 30 years ago, it is often contaminated with fungi, pesticides and heavy metals.

"There's a stereotype, a hippy kind of mentality, that leads people to assume that growers are using natural cultivation methods and growing organically," said Andy LaFrate, founder of Charas Scientific, one of eight labs in Colorado certified to test marijuana. "That's not necessarily the case at all."

LaFrate presented his findings this week at a meeting of the American Chemical Society (ACS) in Denver.

LaFrate said his group has tested more than 600 strains of marijuana from dozens of producers. Potency tests looked at tetrahydrocannabinol (THC), the principal psychoactive component responsible for the high. They found that modern cannabis contains THC levels of 18 to 30 percent, double to triple averages from the 1980s.

Breeding for more THC has led to less cannabidiol (CBD), a compound which is also medically beneficial in treating anxiety, depression, schizophrenia, Huntington's, Alzheimer's, epilepsy, seizures and other conditions. Much of the commercial marijuana tested had very little CBD.

"A lot of the time it's below the detection level of our equipment, or it's there at a very low concentration that we just categorize as a trace amount," LaFrate said.
"I've heard a lot of complains from medical patients because somebody claims that a product has a high level of CBD, and it turns out that it actually doesn't."

Texas: Lawmakers Hold News Conference On Medical Marijuana Legislation

MarisaMarquezTexasStateRepresentative[TheTexasTribune]

State Rep. Marisa Márquez (D-El Paso) and other Texas legislators will hold a news conference Tuesday at 1:30 p.m. CT in the Speaker’s Committee Room to discuss HB 3785 and SB 1839. They will be joined by Fort Worth cancer patient Barbara Humphries and other seriously ill Texans.

HB 3785, introduced by Rep. Márquez in the House, and SB 1839, introduced by Sen. José Menéndez (D-San Antonio) in the Senate, would allow patients with cancer, seizure disorders, post-traumatic stress disorder (PTSD), and other debilitating conditions to access medical marijuana if their doctors recommend it. It would also allow the Department of State Health Services to establish a tightly regulated system of licensed marijuana cultivators, processors, and dispensaries.

The bills differ from previously introduced legislation that would allow access to CBD oils with little or no THC. Many patients have found that THC and other components of whole marijuana are needed in addition to CBD in order to effectively treat their conditions. Some have relocated to states with more comprehensive medical marijuana laws so that they can access whole marijuana and oils that include a more balanced ratio of CBD and THC.

“Thousands of Texas veterans use medical cannabis to treat PTSD, chronic pain, and other service-related disabilities,” said retired U.S. Army Major David Bass. “Veterans should not have to flee the state or depend on the criminal market to access the medication that best fits their needs. Now is the time for Texas to approve safe and legal access to therapeutic cannabis.”

Texas: Lawmakers Introduce Comprehensive Medical Marijuana Bill

TexansForResponsibleMarijuanaPolicy

Measures introduced in the House and Senate on Friday would allow patients with debilitating conditions — including veterans with PTSD — to access medical marijuana if their doctors recommend it

Texas state lawmakers on Friday introduced legislation that would allow patients with cancer, seizure disorders, post-traumatic stress disorder, and other debilitating conditions to access medical marijuana if their doctors recommend it.

HB 3785, introduced by Rep. Marisa Márquez (D-El Paso) in the House, and a companion bill that will be introduced later Friday by Sen. José Menéndez (D-San Antonio) in the Senate, would create a program through which individuals with qualifying medical conditions would receive licenses allowing them to possess limited amounts of medical marijuana if their doctors recommend it. It would also direct the Department of State Health Services to establish a tightly regulated system of licensed marijuana cultivators, processors, and dispensaries.

“The law currently does not reflect marijuana’s legitimate medical use and denies access to patients, such as veterans with post-traumatic stress disorder, citizens suffering with cancer, and severe aliments of the aging,” Rep. Márquez said. “By continuing to deny access to patients, we limit the rights of families to seek the best possible treatment for conditions that do not respond to other drugs or therapies.

New Mexico: Steep Hill Receives First Provisional Approval For Lab Cannabis Testing

SteepHill(logo)

Steep Hill, which specializes in cannabis testing and analytics in the United States and internationally, has announced intends to open a full service medical cannabis quality assurance laboratory in Albuquerque, New Mexico, bringing advanced scientific tools and methodology to the state, for regulatory oversight of cannabis.

Steep Hill is currently the only laboratory licensed by the New Mexico Department of Health to conduct potency and contaminant testing in order to meet the recently adopted regulatory requirements pertaining to cannabis safety for medical patients in New Mexico, according to a prepared statement from the company.

"We are excited to bring our entire suite of products to New Mexico, including our QuantaCann2™ - an advanced cloud-based potency monitoring system," said David Lampach, CEO and cofounder of Steep Hill. "This will enable the state to meet its THC and CBD testing requirements, while also providing regulators with a real time window into the marketplace."

The State of New Mexico requires regular testing be done in a Department of Health approved laboratory as the only acceptable method to determine the quality, purity and potency required for the sale of medical cannabis products.

For more information about cannabis testing, you can visit the Steep Hill website: http://steephill.com

About Steep Hill

U.S.: Company Announces Pure CBD Available To The Public

CBDPureUS.com(logo)

CBDpurUS.com, a supplier of pure natural CBD isolate (not a synthetic) in the United States, on Thursday announced that the medical and research community, as well as members of the public, can order CBD isolate from the company in 1 gram, 5 g, 10 g, 25 g and 50 g sizes. Delivery normally takes 72 hours.

Because this isolate is pure CBD, it is normally diluted by dissolving it in canola oil, sunflower oil, hemp seed oil, etc. The oil is heated to 155 degrees and the Pure CBD is dissolved therein.

Dosages of 10 mg to 25 mg are the most common. The individual's body naturally determines the amount of strength needed daily for relief. Thus we see 1g of CBD isolate will produce forty 25 mg doses when diluted in oil. This equates to a huge savings for patients in addition to research, manufacturing, etc.

Oregon Analytical Services has tested the CBD to be 99.8 percent pure, according to CBDpurUS.com. They suggest the oil be delivered in a eye dropper that can be obtained from any pharmacy.

The drops should be placed under the tongue and held there for maximum delivery via the sublingual, buccal, and Peroral membranes of the the body.

U.S.: Organic Cannabis CBD Infused Fitness Drink Now Being Distributed Nationwide

PyoorCBD(logofromsite)

PyoorCBD on Wednesday announced they will begin to distribute their Cibamine Xtra CBD Infused Drink Additive and 7 Hour Sleep CBD Formula for the United States market.

Both formulas are PassionFruit flavored all natural, zero calorie, sugar free, gluten free, GMO free drink shots/additives that uses Carlsbad Alkaline Water as their water source for their formulas. The company already has these available for sale in THC Formulas in more 200 medical marijuana dispensaries throughout California.

In the company's product line are Energy Drinks CBD and THC Infused, a complete pre- and post- workout supplement line infused with CBD Cannabinoids and Hemp to assist with muscle fatigue, rehabilitation from inflammation and extreme workout overload.

PyoorCBD says its products are herbicide and pesticide free, peanut-free, vegetarian approved, kosher certified, THC-free (NO THC, 100 percent legal), and tryspin inhibitor free.

PyoorCBD has developed a line of cannabis infused products targeting the health and fitness conscious consumer. The product line includes products developed in-house as well as products from partners that compliment the overall product line.

In partnership with an established health and fitness recognized brand name partner, PyoorCBD has a pilot retail store in San Diego to market cannabis infused beverages and food supplements. The products are infused with Hemp to include CBD, which is legal in all 50 states. Formulas that include THC are for when and where laws permit.

U.S.: Corporation Files 2nd Patent Application For CBD/Ibuprofen Pain Combo

CBD/IbuprofenPackage(SteviaCorp)

Stevia Corp., an international farm management company and healthcare company, has announced the filing of a second important provisional patent application with the United States Patent and Trademark Office for pain treatment using a combination of ibuprofen and cannabidiol (CBD).

The provisional patent application closely follows the company's previously announced first provisional patent application for pain management using acetaminophen and CBD. As in the previous application, this patent includes multiple claims including, but not limited to, combinations of cannabinoids including CBD and ibuprofen for the treatment of pain.

The provisional patent application, a legal document which establishes an early priority date for the benefit of claiming "first to file" status against other companies or individuals, "was filed with the assistance of an intellectual property attorney with extensive experience in the healthcare industry," according to a prepared statement from Stevia Corp.

CBD is a cannabinoid present in most varieties of the cannabis sativa and cannabis indica plants. Unlike THC and some of the other molecules found in cannabis, CBD is non-psychoactive.

CBD is also extremely well tolerated at high doses with little or no side effects; it is essentially non-toxic. It catapulted to national prominence after being an important part of Dr. Sanjay Gupta's 2013 CNN documentary, "Weed."

U.S.: Dose of Nature Introduces New CBD Product Line

DoseOfNature

Utah-based Dose of Nature last week launched a state-of-the-art CBD (cannabidiol) product line, applying proprietary technologies to create what it calls "the first nano CBD and water-soluble CBD products in the market."

CBD has been at the forefront of the news lately in its application to treat pediatric epilepsy, autism, cancer, pain, PTSD, brain injuries, anxiety, and various neurological conditions.

Most CBD pastes or oils being used today have a very strong taste and are slowly and poorly absorbed into the body. Dose of Nature says it addresses these issues using its proprietary Hydrosome™ and BioXTrax™ technologies, making water-soluble CBD taste better, more rapidly absorbed, and more bioavailable within minutes of ingestion.

"The Hydrosome™ technology represents a shift in how nutritional supplements, and even pharmaceuticals, can be delivered," said Dr. Rick Potts, president of Dose of Nature. "This integrative approach is far superior to liposomes in terms of unlocking the true potential of natural remedies, optimizing the speed and breadth of nutrient delivery throughout the body."

The new Dose of Nature product line will include:

• Sweet CBD™: this water-soluble form of concentrated CBD is readily absorbed in the stomach, and is created through a multiplex bonding process of highly-refined RedStrap CBD Oil to 100% vegetable glycerin without the need for preservatives, flavors, or emulsifying agents.

Syndicate content